Professor of Medical Oncology, Case West Res University
Hematology
Dr. Hillard M. Lazarus, MD
|
|
Give Review
Hillard M. Lazarus, MD works in the field of Hematology. He graduated from University of Rochester School of Medicine and Dentistry. He has 21 awards "America's Top Doctors", "Honorary Alumnus of the Year Award", "America's Top Doctors for Cancer", "The George & Edith Richman Professor & Distinguished Scientist in Cancer Research", "Hematology and Oncology Faculty Award for Excellence in Fellow Education", "Alumni Distinguished Service Award", "Man of the Year (Northern Ohio)", "Northern Ohio Live", "Cancer Care Hall of Fame", "Research Award The Standing Tall Tribute (Lifetime Achievement)", "Teaching Award in Clinical Oncology", "Special Fellow", "Junior Faculty Clinical Fellow", "Clark Dunlop Cancer Research Fund Award", "American Cancer Society", "Dr. Glenn H. Leak Memorial Summer Oncology Fellowship", "Alpha Omega Alpha", "Tau Beta Pi", "Phi Kappa Phi", "Omicron Delta Kappa" and "Pi Delta Epsilon". Hillard Lazarus is a published doctor and has 103 publications published. The lastest was: 'Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary.' He is registered with Medicare and accepts Medicare payments.
Publications
- Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
- Dual institution experience of extranodal marginal zone Lymphoma reveals excellent long-term outcomes.
- A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic Leukemia in old...
- Favorable outcome to glucocorticoid therapy for enGraftment syndrome in pediatric autologous hematopoietic cell transplant.
- Pediatric-inspired therapy compared to alloGrafting for Philadelphia chromosome-negative adult ALL in first complete remission.
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
- Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Maximizing anthracycline tolerability in hematologic Malignancies: Treat to each heart's content.
- Early Passage Dependence of Mesenchymal Stem Cell Mechanics Influences Cellular Invasion and Migration.
- Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
- Post-autologous transplant maintenance therapies in lymphoid Malignancies: are we there yet?
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin Lymphoma.
- Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic...
- New Cancers after autotransplantations for multiple myeloma.
- Secondary solid Cancer screening following hematopoietic cell transplantation.
- The devil is in the details: confidentiality challenges in the age of genetics.
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation.
- EnGraftment syndrome, the Emperor's new clothes and the artist formerly known as prince.
- Multiple skin Cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia.
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for Inter...
- Not too little, not too much-just right! (Better ways to give high dose melphalan).
- Hospital Length of Stay in the First 100Â Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft S...
- Autologous GVHD?
- Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
- Immunosuppressive therapy of LGL Leukemia: prospective multicenter phase II study by the eastern cooperative oncology group (E5998).
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- All in the family: Clueing into the link between metabolic syndrome and hematologic Malignancies.
- Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
- Double Umbilical Cord Blood Transplantation: Relevance of Persistent Mixed Unit Chimerism.
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Second solid Cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
- Younger adults with Acute myeloid leukemia in remission for â¥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients.
- Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for Acute lymphoblastic leukemia.
- Geoffrey peter herzig, MD (1941-2013): transplant pioneer.
- Effect of body mass in children with hematologic Malignancies undergoing allogeneic bone marrow transplantation.
- Should Persons with Acute Myeloid Leukemia Have a Transplant in 1st Remission?
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Clinical guide to fertility preservation in hematopoietic cell transplant recipients.
- Allogeneic hematopoietic cell transplantation for diffuse large B cell Lymphoma: who, when and how?
- Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin Lymphoma.
- A Community-Based Exercise and Support Group Program in African-American Breast Cancer Survivors (ABCs).
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for Acute myeloid leukemia in first complete remission.
- Many are Called but Few are Chosen: Under-utilization of Unrelated Donor Transplantation.
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- Trimming the fat: obesity and hematopoietic cell transplantation.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Cutaneous complications in hematopoietic cell transplant recipients: impact of biopsy on patient management.
- Umbilical cord blood Graft enhancement strategies: has the time come to move these into the clinic?
- Prevalence of Hematopoietic Cell Transplant Survivors in the United States.
- Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for Lymphoma and mye...
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in Acute myeloid leukemia.
- Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of...
- To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for Acute myeloid leukemia: a study from the cibmtr.
- Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
- Renal alloGrafts in plasma cell myeloma hematopoietic cell Graft recipients: on the verge of an explosion?
- Second Malignancies after autologous hematopoietic cell transplantation in children.
- New strategies for the evaluation of the nadir bone marrow following induction in Acute myeloid leukemia.
- Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.
- Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients.
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
- Autologous and allogeneic transplantation for burkitt Lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transpl...
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- The functional duality of HoxB4 in hematopoietic reconstituting cells.
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
- Acute myeloid leukemia with translocation t(8;16) presents with features which mimic Acute promyelocytic leukemia and is associated with poor prognosis.
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- Achieving Graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.
- Refining hematopoietic cell transplant: A concise review.
- Percutaneous Image-guided Delivery for the Transplantation of Mesenchymal Stem Cells in the Setting of Degenerated Intervertebral Discs.
- Salvage chemotherapy and autologous hematopoietic cell transplant in primary refractory diffuse large B-cell Lymphoma: progress or better patient selection?
- Allogeneic hematopoietic cell transplantation for Acute myeloid leukemia in first complete remission: have the indications changed?
- Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure.
- Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin Lymphoma using lower intensity conditioning: a report from the CIBMTR.
- Novel transplant strategies in adults with Acute leukemia.
- Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with Leukemia and myelodysplastic syndromes.
- Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared to children and older adults with Acute myeloid leukemia.
- Redefining Transplant in Acute Leukemia.
- Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for Acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials...
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Incidence of Therapy-related Myeloid Neoplasia after Initial Therapy for CLL with Fludarabine-Cyclophosphamide versus Fludarabine: Long-Term Follow-up of US Intergroup...
- Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast Cancer following negative trial results.
- Donor characteristics affecting Graft failure, Graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for he...
- Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple Myeloma.
- Trends in allogeneic stem cell transplantation for multiple Myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
- Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- Spontaneous Autologous Graft-versus-Host Disease in Plasma Cell Myeloma AutoGraft Recipients: Flow Cytometric Analysis of Hematopoietic Progenitor Cell Grafts.
- Cord blood transplant for Acute myeloid leukaemia.
- Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary.
Schools
University Of Rochester School Of Medicine and Dentistry
University Hosps
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Honorary Alumnus of the Year Award
- America's Top Doctors for Cancer
- The George & Edith Richman Professor & Distinguished Scientist in Cancer Research
- Hematology and Oncology Faculty Award for Excellence in Fellow Education
- Alumni Distinguished Service Award
- Man of the Year (Northern Ohio)
- Northern Ohio Live
- Cancer Care Hall of Fame
- Research Award “The Standing Tall Tribute†(Lifetime Achievement)
- Teaching Award in Clinical Oncology
- Special Fellow
- Junior Faculty Clinical Fellow
- Clark Dunlop Cancer Research Fund Award
- American Cancer Society
- Dr. Glenn H. Leak Memorial Summer Oncology Fellowship
- Alpha Omega Alpha
- Tau Beta Pi
- Phi Kappa Phi
- Omicron Delta Kappa
- Pi Delta Epsilon
Education
-
Case Western Reserve University - University Hospitals -
University of Rochester School of Medicine and Dentistry
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1255351920 | |
| NPPES Provider LastName | LAZARUS | |
| NPPES Provider FirstName | HILLARD | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 189.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1255351920 |
| Last Name Of The Provider | LAZARUS |
| First Name Of The Provider | HILLARD |
| View All |
Similar Doctors
|
Dr. Matt E. Kalaycio, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aric W. Greenfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hoon Park, MD |
|
|
Dr. Ramon V. Tiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hamed Daw, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Clark W. Distelhorst, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelina A. Bautista, MD |
|
|
Dr. Meredith E. Driscol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ila Tamaskar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas D. Walsh, MD |
|
|
Dr. Shaveta Vinayak, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory P. Warren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul F. Hergenroeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaroslaw P. Maciejewski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick C. Ma, MD |
|
|
Dr. Ming Chi, MD |
|
|
Dr. Mark Cooper, MD |